Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Loxapine vs IM Haloperidol/Lorazepam for Agitation
NCT03110900Phase 4Terminated
- Sponsor
- University of Arkansas
- Start
- Sep 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of loxapine in psychomotor agitation, sponsored by University of Arkansas. Started Sep 2017; status: terminated.
02
Drugs
loxapine
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT03110900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110900.